Compare Bank of Montreal (BMO) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Montreal vs Davita Inc — how do they compare? Bank of Montreal trades at $180.98 (market cap $124.81B), while Davita Inc trades at $232.01 (market cap $15.12B). The key difference: Bank of Montreal is far larger — about 8.3× Davita Inc's market cap, and Bank of Montreal pays a 2.77% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| BMO | DVA | |
|---|---|---|
Market Cap | $124.81B | $15.12B |
Sector | Financials | Health |
52-Week High | $180.86 | $235.71 |
52-Week Low | $110.44 | $103.87 |
Dividend Yield | 2.77% | — |
Enterprise Value | — | $27.67B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
